StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Apogee Therapeutics Inc (APGE) PT Lowered to $116 at Deutsche Bank
June 3, 2026 7:14 AM
Deutsche Bank analyst David Hoang lowered the price target on Apogee Therapeutics Inc (NASDAQ:
APGE
) to $116.00 (from $118.00) while maintaining a Buy rating.
Categories
Analyst PT Change
